profit from every $100 of sales.
$0$100
Innospec
$80.21+2.56% today
+4.9% in 1 year
1-year low $65.891-year high $101.41
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $16.94 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Innospec sold, what it kept, and what it did with the cash.
Sales went from $1.96 billion in 2022 to $1.78 billion in 2025, with $117 million of profit last year.
SalesProfit
Innospec handed back more cash to shareholders than it generated last year.
Buybacks $24M$42M
Free cash flow 2025$63M
Bought back its own shares$24M
Paid as dividends$42M
Cash vs. debt$293M vs. $53M
Innospec vs. similar companies
Innospec grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Innospec | 16.9× · Fair price | ||
 PPG Industries | 17.6× · Fair price | ||
 International Flavors & Fragrances | No profit yet | ||
 DuPont de Nemours | No profit yet | ||
 LyondellBasell Industries | No profit yet |
AI analysis
An AI analyst reads Innospec's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,964 | 1,949 | 1,845 | 1,778 | |
| 587 | 591 | 543 | 492 | |
| 187 | 162 | 181 | 156 | |
| 227 | 201 | 225 | 200 | |
| 133 | 139 | 36 | 117 | |
| 5.32 | 5.56 | 1.42 | 4.67 | |
| 29.9% | 30.3% | 29.4% | 27.7% | |
| 9.5% | 8.3% | 9.8% | 8.8% | |
| 6.8% | 7.1% | 1.9% | 6.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,604 | 1,707 | 1,735 | 1,832 |
| Cash | 147 | 204 | 289 | 293 |
| Total debt | 45 | 45 | 45 | 53 |
| Total liabilities | 563 | 558 | 519 | 500 |
| 1,038 | 1,147 | 1,211 | 1,326 | |
| 25 | 25 | 25 | 25 | |
| 13.7% | 10.7% | 11.4% | 9.0% | |
| 12.8% | 12.1% | 2.9% | 8.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 82 | 207 | 185 | 138 | |
| 42 | 77 | 62 | 76 | |
| 39 | 130 | 122 | 63 | |
| Dividends paid | 32 | 35 | 39 | 42 |
| 6 | 1 | 1 | 24 | |
| 7 | 8 | 9 | 8 |
Valuation
- 16.9×
- 16.2×
- –
- 1.5×
- 1.1×
- 31.5×
- 8.7×
- 3.2%
- 5.9%
- 2.2%
Profitability
- 27.7%
- 8.8%
- 6.6%
- 9.4%
- 8.3%
- 8.8%
- 8.7%
- 6.3%
- 9.7%
- 2.9%
Growth
- −3.3%
- −4.3%
- −38.5%
- +10.5%
- +0.2%
Financial health
- -1.4×
- 0.04
- 2.8%
- –
- 2.98
- 2.02
- 0.98
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 40%of 988
Bottom 43%of 948
Top 38%of 768
Bottom 26%of 927
Top 43%of 987
What analysts expect
- Average price target
- $115.00
- Range
- $115.00 – $115.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 1.05 | 1.02 | +2.9% |
| Feb 17, 2026 | 1.50 | 1.26 | +19.0% |
| Nov 4, 2025 | 1.12 | 1.03 | +8.7% |
| Aug 5, 2025 | 1.26 | 1.17 | +7.7% |
| May 8, 2025 | 1.42 | 1.40 | +1.4% |
| Feb 18, 2025 | 1.41 | 1.36 | +3.7% |
| Nov 5, 2024 | 1.35 | 1.35 | +0.0% |
| Aug 6, 2024 | 1.39 | 1.37 | +1.5% |
2.2%of the share price, paid each year
On $1,000 invested$22a year at today's yield, before tax
+10.5%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.61 in 2015 → $1.71 in 2025
How safe it looks
36.4% of its profit
Room to growStretchedMore than it earns: 67.5%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
80Pass
Philip Fisher
39No pass
Peter Lynch
22No pass
Joel Greenblatt
41No pass
Charlie Munger
41No pass
Terry Smith
31No pass
Questions about Innospec
Is Innospec a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Innospec AI analysis
What does Innospec do?
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It is in Chemicals - Specialty.
Does Innospec pay a dividend?
Yes. At today's price the dividend is 2.2% a year, about 36% of its yearly profit. In 2025 it paid out $42.4 million in dividends.
Is Innospec stock halal?
Yes. Innospec passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Innospec stock done over the past year?
Up 4.9% over the past twelve months, to $80.21. It traded between $65.89 and $101.41 and is 20.9% below its high.
Who are Innospec's competitors?
The largest listed companies in the same industry are PPG Industries, International Flavors & Fragrances, DuPont de Nemours and LyondellBasell Industries. The peers table on this page compares their profit, growth and price with Innospec's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.